{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:57Z","timestamp":1787020197310,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Japan Agency of Medical Research and Development","award":["JP18ck0106212"],"award-info":[{"award-number":["JP18ck0106212"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5762-6","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T10:03:04Z","timestamp":1559296984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol"],"prefix":"10.1186","volume":"19","author":[{"given":"Satoru","family":"Miura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4047-2929","authenticated-orcid":false,"given":"Tateaki","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Mitsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Omae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Inano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teiko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriatsu","family":"Tatematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Mouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisao","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Shiotsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Aragane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Higashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"issue":"2","key":"5762_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1152\/physrev.00016.2008","volume":"89","author":"MJ Tisdale","year":"2009","unstructured":"Tisdale MJ. Mechanisms of cancer cachexia. Physiol Rev. 2009;89(2):381\u2013410.","journal-title":"Physiol Rev"},{"issue":"5","key":"5762_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395.","journal-title":"Lancet Oncol"},{"issue":"4","key":"5762_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","volume":"5","author":"S von Haehling","year":"2014","unstructured":"von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J Cachexia Sarcopenia Muscle. 2014;5(4):261\u20133.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"5762_CR4","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00520-014-2534-3","volume":"23","author":"M Kimura","year":"2015","unstructured":"Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T, Hisamatsu Y, Tokito T, Imai H, Akamatsu H, et al. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer. 2015;23(6):1699\u2013708.","journal-title":"Support Care Cancer"},{"issue":"8","key":"5762_CR5","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1007\/s00520-016-3156-8","volume":"24","author":"K Takayama","year":"2016","unstructured":"Takayama K, Atagi S, Imamura F, Tanaka H, Minato K, Harada T, Katakami N, Yokoyama T, Yoshimori K, Takiguchi Y, et al. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Support Care Cancer. 2016;24(8):3473\u201380.","journal-title":"Support Care Cancer"},{"issue":"1","key":"5762_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","volume":"36","author":"J Arends","year":"2017","unstructured":"Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, Fearon K, Hutterer E, Isenring E, Kaasa S, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr (Edinburgh, Scotland). 2017;36(1):11\u201348.","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"5","key":"5762_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/jnci\/djr556","volume":"104","author":"C Baldwin","year":"2012","unstructured":"Baldwin C, Spiro A, Ahern R, Emery PW. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(5):371\u201385.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5762_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.critrevonc.2014.02.005","volume":"91","author":"TR Balstad","year":"2014","unstructured":"Balstad TR, Solheim TS, Strasser F, Kaasa S, Bye A. Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review. Crit Rev Oncol Hematol. 2014;91(2):210\u201321.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"5762_CR9","doi-asserted-by":"publisher","first-page":"e108687","DOI":"10.1371\/journal.pone.0108687","volume":"9","author":"I Bourdel-Marchasson","year":"2014","unstructured":"Bourdel-Marchasson I, Blanc-Bisson C, Doussau A, Germain C, Blanc JF, Dauba J, Lahmar C, Terrebonne E, Lecaille C, Ceccaldi J, et al. Nutritional advice in older patients at risk of malnutrition during treatment for chemotherapy: a two-year randomized controlled trial. PLoS One. 2014;9(9):e108687.","journal-title":"PLoS One"},{"issue":"3","key":"5762_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","volume":"88","author":"GB Stene","year":"2013","unstructured":"Stene GB, Helbostad JL, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM. Effect of physical exercise on muscle mass and strength in cancer patients during treatment--a systematic review. Crit Rev Oncol Hematol. 2013;88(3):573\u201393.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"5762_CR11","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/jcsm.12201","volume":"8","author":"TS Solheim","year":"2017","unstructured":"Solheim TS, Laird BJA, Balstad TR, Stene GB, Bye A, Johns N, Pettersen CH, Fallon M, Fayers P, Fearon K, et al. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle. 2017;8(5):778\u201388.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"5762_CR12","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.clnu.2017.05.027","volume":"37","author":"A Uster","year":"2018","unstructured":"Uster A, Ruehlin M, Mey S, Gisi D, Knols R, Imoberdorf R, Pless M, Ballmer PE. Effects of nutrition and physical exercise intervention in palliative cancer patients: a randomized controlled trial. Clin Nutr (Edinburgh, Scotland). 2018;37(4):1202\u20139.","journal-title":"Clin Nutr (Edinburgh, Scotland)"},{"issue":"35","key":"5762_CR13","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1200\/JCO.2007.12.5435","volume":"25","author":"TK Owonikoko","year":"2007","unstructured":"Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, Ramalingam SS. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol. 2007;25(35):5570\u20137.","journal-title":"J Clin Oncol"},{"issue":"1","key":"5762_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12885-017-3795-2","volume":"17","author":"T Naito","year":"2017","unstructured":"Naito T, Okayama T, Aoyama T, Ohashi T, Masuda Y, Kimura M, Shiozaki H, Murakami H, Kenmotsu H, Taira T, et al. Unfavorable impact of cancer cachexia on activity of daily living and need for inpatient care in elderly patients with advanced non-small-cell lung cancer in Japan: a prospective longitudinal observational study. BMC Cancer. 2017;17(1):800.","journal-title":"BMC Cancer"},{"issue":"1","key":"5762_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12885-017-3562-4","volume":"17","author":"T Naito","year":"2017","unstructured":"Naito T, Okayama T, Aoyama T, Ohashi T, Masuda Y, Kimura M, Shiozaki H, Murakami H, Kenmotsu H, Taira T, et al. Skeletal muscle depletion during chemotherapy has a large impact on physical function in elderly Japanese patients with advanced non-small-cell lung cancer. BMC Cancer. 2017;17(1):571.","journal-title":"BMC Cancer"},{"issue":"1","key":"5762_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/jcsm.12351","volume":"10","author":"T Naito","year":"2019","unstructured":"Naito T, Mitsunaga S, Miura S, Tatematsu N, Inano T, Mouri T, Tsuji T, Higashiguchi T, Inui A, Okayama T, et al. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle. 2019;10(1):73\u201383.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"5762_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4103\/apjon.apjon_21_18","volume":"5","author":"T Mouri","year":"2018","unstructured":"Mouri T, Naito T, Morikawa A, Tatematsu N, Miura S, Okayama T, Omae K, Takayama K. Promotion of behavioral change and the impact on quality of life in elderly patients with advanced Cancer: a physical activity intervention of the multimodal nutrition and exercise treatment for advanced Cancer program. Asia Pac J Oncol Nurs. 2018;5(4):383\u201390.","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"6","key":"5762_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/ageing\/afq102","volume":"39","author":"S Thomas","year":"2010","unstructured":"Thomas S, Mackintosh S, Halbert J. Does the \u2018Otago exercise programme\u2019 reduce mortality and falls in older adults?: a systematic review and meta-analysis. Age Ageing. 2010;39(6):681\u20137.","journal-title":"Age Ageing"},{"issue":"6","key":"5762_CR19","doi-asserted-by":"publisher","first-page":"553.e551","DOI":"10.1016\/j.jamda.2017.03.019","volume":"18","author":"Y Yoshimura","year":"2017","unstructured":"Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for treating sarcopenia: a systematic review and meta-analysis of randomized controlled studies. J Am Med Dir Assoc. 2017;18(6):553.e551\u201316.","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"5762_CR20","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1158\/0008-5472.CAN-15-1740","volume":"76","author":"PT Winnard Jr","year":"2016","unstructured":"Winnard PT Jr, Bharti SK, Penet MF, Marik R, Mironchik Y, Wildes F, Maitra A, Bhujwalla ZM. Detection of pancreatic Cancer-induced Cachexia using a fluorescent myoblast reporter system and analysis of metabolite abundance. Cancer Res. 2016;76(6):1441\u201350.","journal-title":"Cancer Res"},{"issue":"11","key":"5762_CR21","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1007\/s00520-018-4248-4","volume":"26","author":"T Miura","year":"2018","unstructured":"Miura T, Mitsunaga S, Ikeda M, Ohno I, Takahashi H, Suzuki H, Irisawa A, Kuwata T, Ochiai A. Characterization of low active ghrelin ratio in patients with advanced pancreatic cancer. Support Care Cancer. 2018;26(11):3811\u20137.","journal-title":"Support Care Cancer"},{"issue":"5","key":"5762_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/annonc\/mdt551","volume":"25","author":"JF Christensen","year":"2014","unstructured":"Christensen JF, Jones LW, Andersen JL, Daugaard G, Rorth M, Hojman P. Muscle dysfunction in cancer patients. Ann Oncol. 2014;25(5):947\u201358.","journal-title":"Ann Oncol"},{"issue":"5","key":"5762_CR23","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/H08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol, Nutr Metab. 2008;33(5):997\u20131006.","journal-title":"Appl Physiol, Nutr Metab"},{"issue":"7","key":"5762_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/bmc.1346","volume":"24","author":"K Shimbo","year":"2010","unstructured":"Shimbo K, Kubo S, Harada Y, Oonuki T, Yokokura T, Yoshida H, Amao M, Nakamura M, Kageyama N, Yamazaki J, et al. Automated precolumn derivatization system for analyzing physiological amino acids by liquid chromatography\/mass spectrometry. Biomed Chromatogr : BMC. 2010;24(7):683\u201391.","journal-title":"Biomed Chromatogr : BMC"},{"issue":"16","key":"5762_CR25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Woods RL, Nelson MR, Reid CM, Kirpach B, Wolfe R, Storey E, Shah RC, Lockery JE, Tonkin AM, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018;379(16):1499\u2013508.","journal-title":"N Engl J Med"},{"issue":"4","key":"5762_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17(4):519\u201331.","journal-title":"Lancet Oncol"},{"issue":"3","key":"5762_CR27","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1002\/cncr.31128","volume":"124","author":"N Katakami","year":"2018","unstructured":"Katakami N, Uchino J, Yokoyama T, Naito T, Kondo M, Yamada K, Kitajima H, Yoshimori K, Sato K, Saito H, et al. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer. 2018;124(3):606\u201316.","journal-title":"Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5762-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5762-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5762-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T19:09:43Z","timestamp":1590779383000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5762-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5762"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5762-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the principles expressed in the Declaration of Helsinki. The main protocol of this study was approved by the institutional review board of Shizuoka Cancer Center (Trial No. 29\u201312\u201329-1-5) at August 22, 2017. Protocol amendments have been made in the study period and the list of participating institutions. The latest version (version 4.0) of study protocol have been reviewed and approved by the institutional review board in each participating hospital (Additional\u00a0file\u00a0\n                      \n                      ). The latest version of this protocol was approved by each participant site. Written informed consent will be obtained from all the participants. Consents for the ancillary translational research are obtained separately.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SM has received lecture fees from Chugai Pharmaceutical, Bristol-Myers Squibb, MSD, Chugai Pharmaceutical and Eli Lilly Japan. SM has received research funding from Bayer Yakuhin, Chugai Pharmaceutical, Merck Serono, ASLAN Pharmaceuticals, TORAY, Ono Pharmaceutical, and Sumitomo Dainippon Pharma, Ajinomoto Corporation. TT has received lecture fees from AstraZeneca, Chugai Pharmaceutical, and Eli Lilly Japan. TT has also received research funding from Ono Pharmaceutical, MSD, AstraZeneca, Chugai Pharmaceutical, Eli Lilly Japan, and Pfizer. AI has received lecture fees from Kracie Pharma Ltd. and research funding from Kracie Pharma, Ltd. and Saisei Mirai Clinics. KT has received lecture fees from Ono Pharmaceutical, AstraZeneca, Eli Lilly Japan, Chugai Pharmaceutical, Boehringer-Ingelheim, MSD, Daiichi-Sankyo, and Pfizer. KT has also received research funding from Ono Pharmaceutical, Chugai Pharmaceutical, Taiho Pharmaceutical, and Boehringer-Ingelheim. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"528"}}